MNKD Q4 2020 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$813M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$18M+15.3% YoY

Gross Profit

$12M65.9% margin

Operating Income

-$24M-128.8% margin

Net Income

-$26M-143.2% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

+20.1%

Cash Flow

Operating Cash Flow

$235,000

Free Cash Flow

-$4M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$109M

Total Liabilities

$289M

Stockholders' Equity

-$180M

Cash & Equivalents

$67M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$16M	+15.3%
Gross Profit	$12M	$9M	+35.5%
Operating Income	-$24M	-$11M	-109.2%
Net Income	-$26M	-$14M	-85.2%

Revenue Segments

Product

$10M79%

License And Service

$3M21%